European equities traded in the US as American depositary receipts were falling late Monday morning, dropping 2.31% on the S&P Europe Select ADR Index to 1,411.83.
From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies (DBVT) and petroleum refiner Equinor (EQNR), which rose 6.4% and 5.1%, respectively. They were followed by medical device maker EDAP TMS (EDAP) and consumer goods giant Unilever (UL), which were up 4.8% and 3.1%, respectively.
The decliners from continental Europe were led by pharmaceutical company Novo Nordisk (NVO) and financial services company Banco Santander (SAN), which fell 10% and 5.7%, respectively. They were followed by biotech firm Evaxion Biotech (EVAX) and internet browser company Opera (OPRA), which were down 5.3% each.
From the UK and Ireland, the gainers were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and utilities company National Grid (NGG), which advanced 11% and 2.8%, respectively. They were followed by biopharmaceutical company TC Biopharm (TCBP) and oil and gas company BP (BP), which increased 2.3% and 1.4%, respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Verona Pharma (VRNA) and Akari Therapeutics (AKTX), which lost 7.5% and 7.3%, respectively. They were followed by cruise line operator Carnival (CUK) and financial services company Barclays (BCS), which shed 7.2% each.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。